Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus

Stopped early · Phase 2

Conditions studied: Sarcoma

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of paclitaxel in treating patients with recurrent or persistent cancer of the uterus.

Key facts

Study ID
NCT00003054
Run by
Gynecologic Oncology Group
Starts
1997-08-01
Last updated by the study team
2018-04-12

Who can join

Age: any, up to 120. Sex: female. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.